Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination

Venous thrombosis is a rare occurrence following the administration of the COVID‐19 mRNA vaccine. The occurrence of superior mesenteric vein (SMV) is even more rare. SMV thrombosis should be considered as a differential diagnosis in patients who develop abdominal pain after COVID‐19 mRNA vaccination...

Descripción completa

Detalles Bibliográficos
Autores principales: Kubo, Takahiro, Kawaratani, Hideto, Yoshiji, Hitoshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Images
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196657/
https://www.ncbi.nlm.nih.gov/pubmed/37215973
http://dx.doi.org/10.1002/ccr3.7354
_version_ 1785044394705944576
author Kubo, Takahiro
Kawaratani, Hideto
Yoshiji, Hitoshi
author_facet Kubo, Takahiro
Kawaratani, Hideto
Yoshiji, Hitoshi
author_sort Kubo, Takahiro
collection PubMed
description Venous thrombosis is a rare occurrence following the administration of the COVID‐19 mRNA vaccine. The occurrence of superior mesenteric vein (SMV) is even more rare. SMV thrombosis should be considered as a differential diagnosis in patients who develop abdominal pain after COVID‐19 mRNA vaccination.
format Online
Article
Text
id pubmed-10196657
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101966572023-05-20 Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination Kubo, Takahiro Kawaratani, Hideto Yoshiji, Hitoshi Clin Case Rep Case Images Venous thrombosis is a rare occurrence following the administration of the COVID‐19 mRNA vaccine. The occurrence of superior mesenteric vein (SMV) is even more rare. SMV thrombosis should be considered as a differential diagnosis in patients who develop abdominal pain after COVID‐19 mRNA vaccination. John Wiley and Sons Inc. 2023-05-18 /pmc/articles/PMC10196657/ /pubmed/37215973 http://dx.doi.org/10.1002/ccr3.7354 Text en © 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Images
Kubo, Takahiro
Kawaratani, Hideto
Yoshiji, Hitoshi
Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination
title Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination
title_full Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination
title_fullStr Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination
title_full_unstemmed Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination
title_short Severe superior mesenteric vein thrombosis after COVID‐19 mRNA vaccination
title_sort severe superior mesenteric vein thrombosis after covid‐19 mrna vaccination
topic Case Images
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196657/
https://www.ncbi.nlm.nih.gov/pubmed/37215973
http://dx.doi.org/10.1002/ccr3.7354
work_keys_str_mv AT kubotakahiro severesuperiormesentericveinthrombosisaftercovid19mrnavaccination
AT kawaratanihideto severesuperiormesentericveinthrombosisaftercovid19mrnavaccination
AT yoshijihitoshi severesuperiormesentericveinthrombosisaftercovid19mrnavaccination

Ejemplares similares